Completed
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
NCT01215747
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Raffi Minasian MD a Medical Corporation Glendale, California, United States
- Boston Medical Center Boston, Massachusetts, United States
- Ohio State University Medical Center Columbus, Ohio, United States
- UZ Leuven Leuven, Belgium